Baidu
map

Science:甲基修饰抑制TLR13识别23S rRNA引发细菌耐药

2012-07-20 songbo 生物谷

7月19日,Science在线报道,TLR13受体可识别一类保守的23S核糖体RNA序列,以及一种围绕该相互作用的细菌耐药机制。 保护宿主免受感染的机制依赖于识别受体,如Toll样受体(TLRs),以与生俱来的模式识别病原体。 本研究证实,在小鼠体内,孤儿受体TLR13识别一个细菌内保守的23S核糖体RNA(rRNA)序列。该序列是大环内酯类,林肯酰胺以及链霉杀阳菌素类(MLS)抗生素(包括红

7月19日,Science在线报道,TLR13受体可识别一类保守的23S核糖体RNA序列,以及一种围绕该相互作用的细菌耐药机制。

保护宿主免受感染的机制依赖于识别受体,如Toll样受体(TLRs),以与生俱来的模式识别病原体。

本研究证实,在小鼠体内,孤儿受体TLR13识别一个细菌内保守的23S核糖体RNA(rRNA)序列。该序列是大环内酯类,林肯酰胺以及链霉杀阳菌素类(MLS)抗生素(包括红霉素)的结合位点。

值得注意的是,源自从临床分离的耐红霉素金黄色葡萄球菌的23S rRNA和带甲基化腺苷或鸟苷的合成寡核苷酸可模拟导致 MLS抵抗的修饰。此修饰的结果是不能激活TLR13。

总之,该研究结果发现了一个天然TLR13配体,以及一种引发抗生素耐药性的具体机制。该机制通过避免TLR13介导的识别,作为细菌强有力的免疫逃避策略。

doi:10.1016/j.cell.2011.10.017
PMC:
PMID:

TLR13 Recognizes Bacterial 23S rRNA Devoid of Erythromycin Resistance–Forming Modification

Marina Oldenburg1,*,Anne Krüger1,*,Ruth Ferstl2,*,?,Andreas Kaufmann3,Gernot Nees3,Anna Sigmund1,Barbara Bathke4,Henning Lauterbach4,Mark Suter4,5,Stefan Dreher2,Uwe Koedel6,Shizuo Akira7,Taro Kawai7,Jan Buer1,Hermann Wagner2,Stefan Bauer3,Hubertus Hochrein4,*,Carsten J. Kirschning

Host protection from infection relies on the recognition of pathogens by innate pattern recognition receptors such as Toll-like receptors (TLRs). Here, we show that the orphan receptor TLR13 in mice recognizes a conserved 23S ribosomal RNA (rRNA) sequence that is the binding site of macrolide, lincosamide, and streptogramin group (MLS) antibiotics (including erythromycin) in bacteria. Notably, 23S rRNA from clinical isolates of erythromycin-resistant S. aureus and synthetic oligoribonucleotides carrying methylated adenosine or a guanosine mimicking a MLS resistance–causing modification failed to stimulate TLR13. Our results thus reveal both a natural TLR13 ligand and specific mechanisms of antibiotic resistance as potent bacterial immune evasion strategy, avoiding recognition via TLR13.

版权声明:
本网站所有内容来源注明为“梅斯医学”或“MedSci原创”的文字、图片和音视频资料,版权均属于梅斯医学所有。非经授权,任何媒体、网站或个人不得转载,授权转载时须注明来源为“梅斯医学”。其它来源的文章系转载文章,或“梅斯号”自媒体发布的文章,仅系出于传递更多信息之目的,本站仅负责审核内容合规,其内容不代表本站立场,本站不负责内容的准确性和版权。如果存在侵权、或不希望被转载的媒体或个人可与我们联系,我们将立即进行删除处理。
在此留言
评论区 (6)
#插入话题
  1. [GetPortalCommentsPageByObjectIdResponse(id=1795756, encodeId=7c871e9575662, content=<a href='/topic/show?id=e6011e532bc' target=_blank style='color:#2F92EE;'>#TLR13#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=64, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=17532, encryptionId=e6011e532bc, topicName=TLR13)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=3fce464, createdName=ylz8403, createdTime=Sat Mar 09 13:04:00 CST 2013, time=2013-03-09, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1656443, encodeId=0cbc165644323, content=<a href='/topic/show?id=a33e15684fd' target=_blank style='color:#2F92EE;'>#rRNA#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=71, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=15684, encryptionId=a33e15684fd, topicName=rRNA)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=e9ef24842227, createdName=steven_u10, createdTime=Mon Nov 19 01:04:00 CST 2012, time=2012-11-19, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1746591, encodeId=5d5c1e46591da, content=<a href='/topic/show?id=989d1e525e5' target=_blank style='color:#2F92EE;'>#TLR#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=68, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=17525, encryptionId=989d1e525e5, topicName=TLR)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=bd2d35803070, createdName=lilianxiang, createdTime=Wed Sep 19 05:04:00 CST 2012, time=2012-09-19, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1374662, encodeId=736513e4662f5, content=<a href='/topic/show?id=2949159989d' target=_blank style='color:#2F92EE;'>#SCIE#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=66, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=15998, encryptionId=2949159989d, topicName=SCIE)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=17a3387, createdName=jichang, createdTime=Sun Jul 22 06:04:00 CST 2012, time=2012-07-22, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1569250, encodeId=f2641569250ad, content=<a href='/topic/show?id=1c562e42646' target=_blank style='color:#2F92EE;'>#修饰#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=62, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=27426, encryptionId=1c562e42646, topicName=修饰)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=29c615505859, createdName=zhangyxzsh, createdTime=Sun Jul 22 06:04:00 CST 2012, time=2012-07-22, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1586893, encodeId=890a15868935a, content=<a href='/topic/show?id=e2d3e8130f4' target=_blank style='color:#2F92EE;'>#细菌耐药#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=65, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=78130, encryptionId=e2d3e8130f4, topicName=细菌耐药)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=690d17392347, createdName=yilong5287548, createdTime=Sun Jul 22 06:04:00 CST 2012, time=2012-07-22, status=1, ipAttribution=)]
    2013-03-09 ylz8403
  2. [GetPortalCommentsPageByObjectIdResponse(id=1795756, encodeId=7c871e9575662, content=<a href='/topic/show?id=e6011e532bc' target=_blank style='color:#2F92EE;'>#TLR13#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=64, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=17532, encryptionId=e6011e532bc, topicName=TLR13)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=3fce464, createdName=ylz8403, createdTime=Sat Mar 09 13:04:00 CST 2013, time=2013-03-09, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1656443, encodeId=0cbc165644323, content=<a href='/topic/show?id=a33e15684fd' target=_blank style='color:#2F92EE;'>#rRNA#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=71, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=15684, encryptionId=a33e15684fd, topicName=rRNA)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=e9ef24842227, createdName=steven_u10, createdTime=Mon Nov 19 01:04:00 CST 2012, time=2012-11-19, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1746591, encodeId=5d5c1e46591da, content=<a href='/topic/show?id=989d1e525e5' target=_blank style='color:#2F92EE;'>#TLR#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=68, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=17525, encryptionId=989d1e525e5, topicName=TLR)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=bd2d35803070, createdName=lilianxiang, createdTime=Wed Sep 19 05:04:00 CST 2012, time=2012-09-19, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1374662, encodeId=736513e4662f5, content=<a href='/topic/show?id=2949159989d' target=_blank style='color:#2F92EE;'>#SCIE#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=66, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=15998, encryptionId=2949159989d, topicName=SCIE)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=17a3387, createdName=jichang, createdTime=Sun Jul 22 06:04:00 CST 2012, time=2012-07-22, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1569250, encodeId=f2641569250ad, content=<a href='/topic/show?id=1c562e42646' target=_blank style='color:#2F92EE;'>#修饰#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=62, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=27426, encryptionId=1c562e42646, topicName=修饰)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=29c615505859, createdName=zhangyxzsh, createdTime=Sun Jul 22 06:04:00 CST 2012, time=2012-07-22, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1586893, encodeId=890a15868935a, content=<a href='/topic/show?id=e2d3e8130f4' target=_blank style='color:#2F92EE;'>#细菌耐药#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=65, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=78130, encryptionId=e2d3e8130f4, topicName=细菌耐药)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=690d17392347, createdName=yilong5287548, createdTime=Sun Jul 22 06:04:00 CST 2012, time=2012-07-22, status=1, ipAttribution=)]
    2012-11-19 steven_u10
  3. [GetPortalCommentsPageByObjectIdResponse(id=1795756, encodeId=7c871e9575662, content=<a href='/topic/show?id=e6011e532bc' target=_blank style='color:#2F92EE;'>#TLR13#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=64, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=17532, encryptionId=e6011e532bc, topicName=TLR13)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=3fce464, createdName=ylz8403, createdTime=Sat Mar 09 13:04:00 CST 2013, time=2013-03-09, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1656443, encodeId=0cbc165644323, content=<a href='/topic/show?id=a33e15684fd' target=_blank style='color:#2F92EE;'>#rRNA#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=71, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=15684, encryptionId=a33e15684fd, topicName=rRNA)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=e9ef24842227, createdName=steven_u10, createdTime=Mon Nov 19 01:04:00 CST 2012, time=2012-11-19, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1746591, encodeId=5d5c1e46591da, content=<a href='/topic/show?id=989d1e525e5' target=_blank style='color:#2F92EE;'>#TLR#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=68, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=17525, encryptionId=989d1e525e5, topicName=TLR)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=bd2d35803070, createdName=lilianxiang, createdTime=Wed Sep 19 05:04:00 CST 2012, time=2012-09-19, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1374662, encodeId=736513e4662f5, content=<a href='/topic/show?id=2949159989d' target=_blank style='color:#2F92EE;'>#SCIE#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=66, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=15998, encryptionId=2949159989d, topicName=SCIE)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=17a3387, createdName=jichang, createdTime=Sun Jul 22 06:04:00 CST 2012, time=2012-07-22, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1569250, encodeId=f2641569250ad, content=<a href='/topic/show?id=1c562e42646' target=_blank style='color:#2F92EE;'>#修饰#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=62, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=27426, encryptionId=1c562e42646, topicName=修饰)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=29c615505859, createdName=zhangyxzsh, createdTime=Sun Jul 22 06:04:00 CST 2012, time=2012-07-22, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1586893, encodeId=890a15868935a, content=<a href='/topic/show?id=e2d3e8130f4' target=_blank style='color:#2F92EE;'>#细菌耐药#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=65, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=78130, encryptionId=e2d3e8130f4, topicName=细菌耐药)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=690d17392347, createdName=yilong5287548, createdTime=Sun Jul 22 06:04:00 CST 2012, time=2012-07-22, status=1, ipAttribution=)]
    2012-09-19 lilianxiang
  4. [GetPortalCommentsPageByObjectIdResponse(id=1795756, encodeId=7c871e9575662, content=<a href='/topic/show?id=e6011e532bc' target=_blank style='color:#2F92EE;'>#TLR13#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=64, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=17532, encryptionId=e6011e532bc, topicName=TLR13)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=3fce464, createdName=ylz8403, createdTime=Sat Mar 09 13:04:00 CST 2013, time=2013-03-09, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1656443, encodeId=0cbc165644323, content=<a href='/topic/show?id=a33e15684fd' target=_blank style='color:#2F92EE;'>#rRNA#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=71, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=15684, encryptionId=a33e15684fd, topicName=rRNA)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=e9ef24842227, createdName=steven_u10, createdTime=Mon Nov 19 01:04:00 CST 2012, time=2012-11-19, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1746591, encodeId=5d5c1e46591da, content=<a href='/topic/show?id=989d1e525e5' target=_blank style='color:#2F92EE;'>#TLR#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=68, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=17525, encryptionId=989d1e525e5, topicName=TLR)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=bd2d35803070, createdName=lilianxiang, createdTime=Wed Sep 19 05:04:00 CST 2012, time=2012-09-19, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1374662, encodeId=736513e4662f5, content=<a href='/topic/show?id=2949159989d' target=_blank style='color:#2F92EE;'>#SCIE#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=66, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=15998, encryptionId=2949159989d, topicName=SCIE)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=17a3387, createdName=jichang, createdTime=Sun Jul 22 06:04:00 CST 2012, time=2012-07-22, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1569250, encodeId=f2641569250ad, content=<a href='/topic/show?id=1c562e42646' target=_blank style='color:#2F92EE;'>#修饰#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=62, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=27426, encryptionId=1c562e42646, topicName=修饰)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=29c615505859, createdName=zhangyxzsh, createdTime=Sun Jul 22 06:04:00 CST 2012, time=2012-07-22, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1586893, encodeId=890a15868935a, content=<a href='/topic/show?id=e2d3e8130f4' target=_blank style='color:#2F92EE;'>#细菌耐药#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=65, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=78130, encryptionId=e2d3e8130f4, topicName=细菌耐药)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=690d17392347, createdName=yilong5287548, createdTime=Sun Jul 22 06:04:00 CST 2012, time=2012-07-22, status=1, ipAttribution=)]
    2012-07-22 jichang
  5. [GetPortalCommentsPageByObjectIdResponse(id=1795756, encodeId=7c871e9575662, content=<a href='/topic/show?id=e6011e532bc' target=_blank style='color:#2F92EE;'>#TLR13#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=64, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=17532, encryptionId=e6011e532bc, topicName=TLR13)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=3fce464, createdName=ylz8403, createdTime=Sat Mar 09 13:04:00 CST 2013, time=2013-03-09, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1656443, encodeId=0cbc165644323, content=<a href='/topic/show?id=a33e15684fd' target=_blank style='color:#2F92EE;'>#rRNA#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=71, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=15684, encryptionId=a33e15684fd, topicName=rRNA)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=e9ef24842227, createdName=steven_u10, createdTime=Mon Nov 19 01:04:00 CST 2012, time=2012-11-19, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1746591, encodeId=5d5c1e46591da, content=<a href='/topic/show?id=989d1e525e5' target=_blank style='color:#2F92EE;'>#TLR#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=68, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=17525, encryptionId=989d1e525e5, topicName=TLR)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=bd2d35803070, createdName=lilianxiang, createdTime=Wed Sep 19 05:04:00 CST 2012, time=2012-09-19, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1374662, encodeId=736513e4662f5, content=<a href='/topic/show?id=2949159989d' target=_blank style='color:#2F92EE;'>#SCIE#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=66, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=15998, encryptionId=2949159989d, topicName=SCIE)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=17a3387, createdName=jichang, createdTime=Sun Jul 22 06:04:00 CST 2012, time=2012-07-22, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1569250, encodeId=f2641569250ad, content=<a href='/topic/show?id=1c562e42646' target=_blank style='color:#2F92EE;'>#修饰#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=62, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=27426, encryptionId=1c562e42646, topicName=修饰)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=29c615505859, createdName=zhangyxzsh, createdTime=Sun Jul 22 06:04:00 CST 2012, time=2012-07-22, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1586893, encodeId=890a15868935a, content=<a href='/topic/show?id=e2d3e8130f4' target=_blank style='color:#2F92EE;'>#细菌耐药#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=65, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=78130, encryptionId=e2d3e8130f4, topicName=细菌耐药)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=690d17392347, createdName=yilong5287548, createdTime=Sun Jul 22 06:04:00 CST 2012, time=2012-07-22, status=1, ipAttribution=)]
    2012-07-22 zhangyxzsh
  6. [GetPortalCommentsPageByObjectIdResponse(id=1795756, encodeId=7c871e9575662, content=<a href='/topic/show?id=e6011e532bc' target=_blank style='color:#2F92EE;'>#TLR13#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=64, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=17532, encryptionId=e6011e532bc, topicName=TLR13)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=3fce464, createdName=ylz8403, createdTime=Sat Mar 09 13:04:00 CST 2013, time=2013-03-09, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1656443, encodeId=0cbc165644323, content=<a href='/topic/show?id=a33e15684fd' target=_blank style='color:#2F92EE;'>#rRNA#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=71, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=15684, encryptionId=a33e15684fd, topicName=rRNA)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=e9ef24842227, createdName=steven_u10, createdTime=Mon Nov 19 01:04:00 CST 2012, time=2012-11-19, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1746591, encodeId=5d5c1e46591da, content=<a href='/topic/show?id=989d1e525e5' target=_blank style='color:#2F92EE;'>#TLR#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=68, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=17525, encryptionId=989d1e525e5, topicName=TLR)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=bd2d35803070, createdName=lilianxiang, createdTime=Wed Sep 19 05:04:00 CST 2012, time=2012-09-19, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1374662, encodeId=736513e4662f5, content=<a href='/topic/show?id=2949159989d' target=_blank style='color:#2F92EE;'>#SCIE#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=66, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=15998, encryptionId=2949159989d, topicName=SCIE)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=17a3387, createdName=jichang, createdTime=Sun Jul 22 06:04:00 CST 2012, time=2012-07-22, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1569250, encodeId=f2641569250ad, content=<a href='/topic/show?id=1c562e42646' target=_blank style='color:#2F92EE;'>#修饰#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=62, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=27426, encryptionId=1c562e42646, topicName=修饰)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=29c615505859, createdName=zhangyxzsh, createdTime=Sun Jul 22 06:04:00 CST 2012, time=2012-07-22, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1586893, encodeId=890a15868935a, content=<a href='/topic/show?id=e2d3e8130f4' target=_blank style='color:#2F92EE;'>#细菌耐药#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=65, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=78130, encryptionId=e2d3e8130f4, topicName=细菌耐药)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=690d17392347, createdName=yilong5287548, createdTime=Sun Jul 22 06:04:00 CST 2012, time=2012-07-22, status=1, ipAttribution=)]

相关资讯

BJC:CACNA2D3基因甲基化可预测乳腺癌扩散风险

在一项新研究中,给一个癌基因加上一种分子“便利贴(post-it note)”能够预测患者乳腺癌扩散的风险。 来自英国伦敦帝国学院(Imperial College London)的英国癌症研究中心研究人员证实CACNA2D3基因上高水平的被称作甲基化的分子修饰与乳腺癌患者体内这种疾病的扩散相关联。2012年7月10日,相关研究成果发表在British Journal of Cancer期刊上。

Clin Epi:西兰花抗癌又添新证据

DNA甲基化(DNA methylation)是最早发现的修饰途径之一,大量研究表明,DNA甲基化能引起染色质结构、DNA构象、DNA稳定性及DNA与蛋白质相互作用方式的改变,从而控制基因表达。DNA甲基化是关闭基因通道的正常操作过程,有助于调控细胞获取DNA基因信息。在癌症疾病中,DNA甲基化进程被打乱。其他一些疾病如心血管疾病、免疫功能低下、神经变性疾病等患者体内同样也存在着DNA甲基化进程紊

Nat Commun:DNA甲基化和肥胖之间的关系

近日,在线发表在Nature Communications杂志上的一项研究论文中,四川农业大学和华大基因研究人员报道了猪脂肪及肌肉组织中的DNA甲基化信息,探究了DNA甲基化与肥胖之间的关系。 肥胖可以被视为一种流行病,在现代社会对人类健康有较大风险。肥胖已成为一些慢性疾病包括糖尿病、心血管疾病和癌症的一个重要的危险因素。据预测到2030年,全球成人人口中约58%的人可能超重或患有肥胖。 为了

Baidu
map
Baidu
map
Baidu
map